SCHEMBL677996

SCHEMBL677996

O=CCNO

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL159380 0.74
SCHEMBL6013871 0.70
SCHEMBL28277024 0.69
SCHEMBL2009490 0.67
SCHEMBL10621131 0.67
SCHEMBL12113169 0.67
SCHEMBL15626471 0.67
SCHEMBL7621913 0.65
SCHEMBL18722155 0.65 EPHX1 (0.31)
SCHEMBL11309703 0.64

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 45 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1992349-B1 CGRP antagonists, their preparation and use as a medicament BOEHRINGER INGELHEIM INT (DE) 2013-07-31 EP claimed
CN-116710423-A Method for producing organic compound 奇华顿股份有限公司 2023-09-05 CN disclosed
US-20210395189-A1 SUBSTITUTED TETRACYCLINE COMPOUNDS PARATEK PHARMACEUTICALS, INC. 2021-12-23 US disclosed
EP-3812372-A2 7-HETEROCYCLYL SUBSTITUTED SANCYCLINE DERIVATIVES FOR TREATING BACTERIAL, VIRAL AND PARASITIC INFECTIONS (E.G. MALARIA) OR INFLAMMATORY DISEASES Paratek Pharmaceuticals, Inc. (US) 2021-04-28 EP disclosed
EP-3045449-A1 TETRACYCLINE DERIVATIVES FOR THE TREATMENT OF BACTERIAL, VIRAL AND PARASITIC INFECTIONS Paratek Pharmaceuticals, Inc. (US) 2016-07-20 EP disclosed
US-20160046561-A1 SUBSTITUTED TETRACYCLINE COMPOUNDS PARATEK PHARMACEUTICALS, INC. 2016-02-18 US disclosed
US-9012433-B2 Substituted tetracycline compounds PARATEK PHARMACEUTICALS, INC. (US) 2015-04-21 US disclosed
US-8653255-B2 Sialic acid derivatives for protein derivatisation and conjugation LIPOXEN TECHNOLOGIES LIMITED (GB) 2014-02-18 US disclosed
EP-2684874-A1 Fused bicyclic derivatives of 2,4-diaminopyrimidine as alk and C-met inhibitors Cephalon, Inc. (US) 2014-01-15 EP disclosed
US-8569239-B2 Glutathione based delivery system INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) 2013-10-29 US disclosed
US-5104982-A ROUTE TO GLYCALS IN THE ALLAL AND GULAL SERIES YALE UNIVERSITY (US) 1992-04-14 US disclosed
EP-0448412-A2 A route to glycals in the allal and gulal series YALE UNIVERSITY (US) 1991-09-25 EP disclosed
WO-1991002739-A1 SYNTHESIS OF GLYCOSIDES HAVING PREDETERMINED STEREOCHEMISTRY YALE UNIVERSITY (US) 1991-03-07 WO disclosed
US-4803263-A Process for the preparation of alkylated glycosyl fluorides free from hydroxyl groups HOECHST AKTIENGESELLSCHAFT (DE) 1989-02-07 US disclosed
US-4281116-A ANTIBIOTICS ELI LILLY AND COMPANY (US) 1981-07-28 US disclosed
US-4260745-A 3-Halo cephalosporins ELI LILLY AND COMPANY (US) 1981-04-07 US disclosed
US-4252950-A ANTIBIOTICS, BACTERICIDES, FUNGICIDES ELI LILLY AND COMPANY (US) 1981-02-24 US disclosed
US-4208515-A 3-Halo cephalosporins ELI LILLY AND COMPANY (US) 1980-06-17 US disclosed
US-4065618-A Process for 3-H-3-cephem esters ELI LILLY AND COMPANY (US) 1977-12-27 US disclosed
US-4064343-A ANTIBIOTICS ELI LILLY AND COMPANY (US) 1977-12-20 US disclosed